25% off all training courses Offer ends May 29, 2026
View HIPAA Courses
25% off all training courses
View HIPAA Courses
Offer ends May 29, 2026

The HIPAA Journal is the leading provider of HIPAA training, news, regulatory updates, and independent compliance advice.

Steve Alder

Steve Alder is the editor-in-chief of The HIPAA Journal. Steve is responsible for editorial policy regarding the topics covered in The HIPAA Journal. He is a specialist on healthcare industry legal and regulatory affairs, and has 10 years of experience writing about HIPAA and other related legal topics. Steve has developed a deep understanding of regulatory issues surrounding the use of information technology in the healthcare industry and has written hundreds of articles on HIPAA-related topics. Steve shapes the editorial policy of The HIPAA Journal, ensuring its comprehensive coverage of critical topics. Steve Alder is considered an authority in the healthcare industry on HIPAA. The HIPAA Journal has evolved into the leading independent authority on HIPAA under Steve’s editorial leadership. Steve manages a team of writers and is responsible for the factual and legal accuracy of all content published on The HIPAA Journal. Steve holds a Bachelor’s of Science degree from the University of Liverpool. You can connect with Steve via LinkedIn or email via stevealder(at)hipaajournal.com

Connexin Software Proposes Class Action Lawsuit Settlement to Avoid Bankruptcy

Connexin Software, which does business as Office Practicum, has proposed a $4 million settlement to resolve a consolidated class action lawsuit stemming from a 2022 data breach that affected almost 3 million individuals. Office Practicum provides pediatric-specific health information technology solutions to healthcare providers, including electronic health records, practice management software, billing services, and business analytics tools. On August 26, 2022, Connexin Software said it detected a data anomaly within its internal network and the subsequent forensic investigation confirmed that an unauthorized third party had obtained an offline set of patient data that was used for data conversion and troubleshooting. The compromised data included the protected health information of 2,675,934 patients, the majority of whom were children. The compromised data included names, guarantor names, parent/guardian names, addresses, email addresses, dates of birth, Social Security numbers, health insurance information, medical and treatment information, and billing and claims data. Several...

Read More
Telemedicine Company Owner Agrees to Plead Guilty in $110 Million Medicare Fraud Scheme
Feb17

Telemedicine Company Owner Agrees to Plead Guilty in $110 Million Medicare Fraud Scheme

The owner of the companies Expansion Media and Hybrid Management Group has agreed to plead guilty to one count of conspiracy to commit healthcare fraud for his role in a $110 million fraud scheme that provided unnecessary durable medical equipment (DME) to Medicare beneficiaries. Between March 2016 and January 2023, Steven Richardson, 40, of Parkland, FL, entered into business relationships with telemarketing companies that generated leads by targeting Medicare beneficiaries. Those companies allegedly paid Richardson’s two companies to generate orders for DME such as back and knee braces for Medicare beneficiaries on a per-order basis. The orders needed to be signed by doctors and nurses who deemed the orthotic devices to be medically necessary. Richardson is alleged to have worked with medical staffing companies to find clinicians willing to review and sign prepopulated orders without having any contact with the Medicare beneficiaries. A signed order indicates that the clinician has performed a legitimate examination of the beneficiary and found the orthotics to be medically...

Read More

Pharmacy CMO Excluded from Federal Healthcare Programs for 6 Years

The former Chief Marketing Officer (CMO) of the New Castle, DE-based pharmacy BioTek reMEDys Inc. (BioTek) has been added to the HHS-OIG exclusions list for 6 years. Carla Sparkler agreed to the 6-year exclusion from Federal healthcare programs to resolve allegations she violated the False Claims Act by paying kickbacks to patients and physicians and waiving co-pays to ensure that BioTek’s revenue stream was protected. Certain medications covered by Medicare require beneficiaries to pay a proportion of the cost in the form of a copayment, coinsurance, or deductible (copays), which were included in the Medicare program by Congress in order to reduce healthcare costs. The Federal Anti-Kickback Statute prohibits the inducement of physicians to prescribe specific medications, payment of remuneration to physicians in exchange for patient referrals, and companies are not permitted to routinely waive the copays of Medicare patients without determination of financial need. Sparkler was alleged to have orchestrated a scheme to provide inducements to physicians and to cover up kickbacks for...

Read More

Pharma Firm Pays $750,000 to Resolve Alleged Violations of the False Claims Act

Sentynl Therapeutics Inc., a Solana Beach, CA-based specialty pharmaceutical company, has agreed to pay a financial penalty of $750,000 to resolve allegations it violated the False Claims Act by causing the submission of claims for opioid medications, in violation of the federal Anti-Kickback Statute. Between December 1, 2015, and August 31, 2016, Sentynl Therapeutics marketed and sold the prescription opioids, Abstral and Levorphanol Tartrate (Levorphanol). Abstral is a Transmucosal Immediate Release Fentanyl (TIRF) medication that is approved by the Food and Drug Administration for the treatment of breakthrough pain in opioid-tolerant cancer patients. Levorphanol is approved by the FDA for the treatment of pain severe enough to require an opioid analgesic when alternative treatments are inadequate. During that time frame, Sentynl Therapeutics is alleged to have knowingly caused the submission of claims for Abstral and Levorphanol to Medicare after making indirect payments of kickbacks to a physician. Sentynl Therapeutics is alleged to have hired the girlfriend of a top prescriber...

Read More

Senator Calls for FTC, SEC to Hold Data Broker Accountable for Misuse of Geolocation Data

U.S. Senator Ron Wyden (D-OR) has written to the Federal Trade Commission (FTC) and the Securities and Exchange Commission (SEC) calling for action to be taken to protect consumers and investors from “the outrageous conduct” of the publicly owned data broker, Near Intelligence Inc. Sen. Wyden launched an investigation in May 2023 of Near Intelligence after a report in The Wall Street Journal revealed the Wisconsin-based non-profit anti-abortion group, The Veritas Society, used geolocation data obtained from Near Intelligence to conduct a misinformation campaign on women suspected of seeking abortion. Geolocation data is collected through code that is incorporated into mobile phone apps. The code receives location data and transfers it along with other information from the user’s device. The data collected reveals a person’s movements, including visits to sensitive locations such as reproductive health clinics, places of worship, healthcare providers, and other sensitive locations. The geolocation data can be tied to an individual and reveals how long they were present at a...

Read More
x

Is Your Organization HIPAA Compliant?

Find Out With Our Free HIPAA Compliance Checklist

Get Free Checklist